Form 483

Cryos International USA, LLC Form 483, 2022-03-08

FDA issued a Form 483 to Cryos International USA, LLC on 2022-03-08 with 20 public-safe observations.

483· Form 483 issuedBiologics20 observations

Cryos International USA, LLC · Orlando, United States · Issued March 8, 2022

Overview

  • 20 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Mar 2022
21 CFR 1271.47(a)

Testing, screening, donor eligibility procedures

Cited by Lura D Baquero

8 Mar 2022
21 CFR 1271.47(a)

Testing, screening, donor eligibility procedures

Cited by Lura D Baquero

8 Mar 2022
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Lura D Baquero

8 Mar 2022
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Lura D Baquero

8 Mar 2022
21 CFR 1271.75(e)

Abbreviated procedure

Cited by Lura D Baquero

Inspected site

CICryos International USA, LLCOrlando, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.47(a)Cited across public-safe Form 483 observations4x
21 CFR 1271.75(a)(1)Cited across public-safe Form 483 observations4x
21 CFR 1271.75(e)Cited across public-safe Form 483 observations4x
21 CFR 1271.85(a)Cited across public-safe Form 483 observations4x
21 CFR 1271.85(d)Cited across public-safe Form 483 observations4x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 20 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere